» Articles » PMID: 30349243

Pure Paclitaxel Nanoparticles: Preparation, Characterization, and Antitumor Effect for Human Liver Cancer SMMC-7721 Cells

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2018 Oct 24
PMID 30349243
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Pure paclitaxel nanoparticles (PPN), consisting entirely of drug molecules, were prepared by the electrostatic spraying method as promising candidates for antitumor application. Compared with the traditional preparation method, the advantage of the electrostatic spraying method included high production rates, relatively small particle sizes, and ease of preparation.

Materials And Methods: Paclitaxel was used to prepared PPN by electrostatic spray. The electrostatic spray device included a constant speed pump with a syringe, a high-voltage power supply, and a metal foil receiver was used to prepare and evaluate PPN. The syringe drew off a certain amount of paclitaxel chloroform solution (150 μg/mL) and was placed on the constant speed injection pump. The dissolution behavior of PPN was evaluated by dissolution test and the presence of paclitaxel in PPN was detected by X-Ray powder diffraction and differential scanning calorimetry. Effect of PPN on SMMC-7721 cells were studied by cell uptake, cell apoptosis and antitumor study.

Results: The results of X-ray powder diffraction and differential scanning calorimetry characterization showed that the PPN were in an amorphous state. A dissolution study indicated that PPN have a significantly enhanced dissolution rate of paclitaxel. Moreover, SMMC-7721 tumor cells treated with PPN exhibited a distinctly high uptake rate that promoted cell apoptosis. An in vivo antitumor study demonstrated that PPN had significant antitumor efficacy.

Conclusion: All conclusions verified that electrostatic spraying is a potential technology for developing PPN, and PPN can be regarded as a promising treatment for cancer.

Citing Articles

Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: and investigation.

Li M, Fang G, Zahid F, Saleem R, Ishrat G, Ali Z Heliyon. 2024; 10(9):e30290.

PMID: 38720725 PMC: 11076978. DOI: 10.1016/j.heliyon.2024.e30290.


Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer.

Lindahl G, Fjellander S, Selvaraj K, Vildeval M, Ali Z, Almter R NPJ Precis Oncol. 2024; 8(1):53.

PMID: 38413842 PMC: 10899227. DOI: 10.1038/s41698-024-00550-9.


Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics.

Pei Q, Jiang B, Hao D, Xie Z Acta Pharm Sin B. 2023; 13(8):3252-3276.

PMID: 37655323 PMC: 10465968. DOI: 10.1016/j.apsb.2023.02.021.


Paclitaxel Delivery to the Brain for Glioblastoma Treatment.

Abdel-Haq M, Kumar A, Ait Mohand F, Kravchenko-Balasha N, Rottenberg Y, Domb A Int J Mol Sci. 2023; 24(14).

PMID: 37511480 PMC: 10380674. DOI: 10.3390/ijms241411722.


Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment.

Bakrania A, Zheng G, Bhat M Pharmaceutics. 2022; 14(1).

PMID: 35056937 PMC: 8779722. DOI: 10.3390/pharmaceutics14010041.


References
1.
Wu Y, MacKay J, McDaniel J, Chilkoti A, Clark R . Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying. Biomacromolecules. 2008; 10(1):19-24. PMC: 2820340. DOI: 10.1021/bm801033f. View

2.
Zhang J, Li Y, An F, Zhang X, Chen X, Lee C . Preparation and size control of sub-100 nm pure nanodrugs. Nano Lett. 2014; 15(1):313-8. DOI: 10.1021/nl503598u. View

3.
Wais U, Jackson A, Zuo Y, Xiang Y, He T, Zhang H . Drug nanoparticles by emulsion-freeze-drying via the employment of branched block copolymer nanoparticles. J Control Release. 2015; 222:141-50. DOI: 10.1016/j.jconrel.2015.12.022. View

4.
Sharma S, Verma A, Teja B, Shukla P, Mishra P . Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies. Eur J Pharm Sci. 2015; 69:51-60. DOI: 10.1016/j.ejps.2014.11.012. View

5.
Szebeni J, Alving C, Savay S, Barenholz Y, Priev A, Danino D . Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions. Int Immunopharmacol. 2001; 1(4):721-35. DOI: 10.1016/s1567-5769(01)00006-6. View